Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | HTR1B | P28222 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27970170 | 1.00 | KDM4E (0.43) | KDM4EL3MBTL1ATMHPGDNR4A2 | |
| SCHEMBL27959988 | 0.93 | KDM4E (0.44) | KDM4EL3MBTL1ATMHPGDNR4A2 | |
| SCHEMBL2269282 | 0.90 | KDM4E (0.47) | KDM4EL3MBTL1ATMHPGDMEN1 | |
| SCHEMBL27964962 | 0.88 | KDM4E (0.46) | KDM4EL3MBTL1ATMHPGDNR4A2 | |
| SCHEMBL15867537 | 0.87 | HPGD (0.37) | KDM4EL3MBTL1ATMHPGDNR4A2 | |
| SCHEMBL18352325 | 0.83 | KDM4E (0.57) | KDM4EL3MBTL1ATMHPGDMEN1 | |
| SCHEMBL15685606 | 0.81 | KDM4E (0.41) | KDM4EL3MBTL1ATMHPGDNR4A2 | |
| SCHEMBL18468317 | 0.81 | KDM4E (0.55) | KDM4EL3MBTL1ATMHPGDMEN1 | |
| SCHEMBL23341615 | 0.80 | L3MBTL1 (0.53) | KDM4EL3MBTL1ATMHPGDMEN1 | |
| SCHEMBL12113746 | 0.80 | L3MBTL1 (0.53) | KDM4EL3MBTL1ATMHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8192847-B2 | Organic electroluminescent device material, organic electroluminescent device, display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-8192847-B2 | Organic electroluminescent device material, organic electroluminescent device, display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | L1CAM, OR10J3, ICOSLG | KDM4E 1687/4885L3MBTL1 191/4885ATM 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.